Prana's PBT434 shows potential as "next-generation" treatment in Parkinson's

08:15 EDT 20 Jun 2013 | thePharmaLetter

Australia-based Prana Biotechnology (ASX: PBT) drug candidate PBT434 shows significant disease-modifying capability in multiple animal models of Parkinson's Disease (PD) with potential utility in a range of movement disorders, according to new data p...

Original Article: Prana's PBT434 shows potential as "next-generation" treatment in Parkinson's

NEXT ARTICLE

More From BioPortfolio on "Prana's PBT434 shows potential as "next-generation" treatment in Parkinson's"

Search BioPortfolio:
Loading
Advertisement
Advertisement

Searches Linking to this Story